Association between the plasma proteome and serum ascorbic acid concentrations in humans

Journal of Nutritional Biochemistry

Volumn 24, Issue 5, 2013, Pages 842-847

  Da Costa, Laura A ^a   García Bailo, Bibiana ^a,b   Borchers, Christoph H ^c   Badawi, Alaa ^b   El Sohemy, Ahmed ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b Office of Biotechnology   (Canada)

^c UNIVERSITY OF VICTORIA   (Canada)

Author keywords

Ascorbic acid; Biomarkers; Plasma proteins; Proteomics; Vitamin C

Indexed keywords

25 HYDROXYVITAMIN D; ALPHA 1 ANTITRYPSIN; ANGIOTENSINOGEN; ASCORBIC ACID; CERULOPLASMIN; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C9; PLASMA PROTEIN; PLASMINOGEN; PROTEOME; VITAMIN D BINDING PROTEIN;

ADULT; ARTICLE; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; MALE; MASS SPECTROMETRY; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEOMICS; QUESTIONNAIRE;

ADULT; ALPHA 1-ANTITRYPSIN; ALPHA-TOCOPHEROL; ANGIOTENSINOGEN; ASCORBIC ACID; CERULOPLASMIN; COMPLEMENT C3; COMPLEMENT C9; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; PROTEOME; PROTEOMICS; QUESTIONNAIRES; YOUNG ADULT;

EID: 84876806124     PISSN: 09552863     EISSN: 18734847     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2012.05.002     Document Type: Article

References (63)

1. García-Bailo B., El-Sohemy A., Haddad P., et al. Vitamins D, C, and E in the prevention of type 2 diabetes mellitus: modulation of inflammation and oxidative stress. Biologics 2011, 5:1-13.
2. May J.M., Qu Z.C., Mendiratta S. Protection and recycling of α-tocopherol in human erythrocytes by intracellular ascorbic acid. Arch Biochem Biophys 1998, 349:281-289.
3. Packer J.E., Slater T.F., Willson R.L. Direct observation of a free radical interaction between vitamin E and vitamin C. Nature 1979, 278:737-738.
4. Padayatty S.J., Katz A., Wang Y., et al. Vitamin C as an antioxidant: evaluation of its role in disease prevention. J Am Coll Nutr 2003, 22:18-35.
5. Cárcamo J.M., Pedraza A., Bórquez-Ojeda O., Golde D.W. Vitamin C suppresses TNFα-induced NFΚB activation by inhibiting IΚBα phosphorylation. Biochemistry 2002, 41:12995-13002.
6. Härtel C., Strunk T., Bucsky P., Schultz C. Effects of vitamin C on intracytoplasmic cytokine production in human whole blood monocytes and lymphocytes. Cytokine 2004, 27:101-106.
7. Ford E.S., Liu S., Mannino D.M., Giles W.H., Smith S.J. C-reactive protein concentration and concentrations of blood vitamins, carotenoids, and selenium among United States adults. Eur J Clin Nutr 2003, 57:1157-1163.
8. Myint P.K., Luben R.N., Wareham N.J., Khaw K.T. Association between plasma vitamin C concentrations and blood pressure in the European Prospective Investigation into Cancer-Norfolk population-based study. Hypertension 2011, 58:372-379.
9. Harding A.H., Wareham N.J., Bingham S.A., et al. Plasma vitamin C level, fruit and vegetable consumption, and the risk of new-onset type 2 diabetes mellitus. The European Prospective Investigation of Cancer-Norfolk prospective study. Arch Intern Med 2008, 168:1493-1499.
10. Beydoun M.A., Shroff M.R., Chen X., Beydoun H.A., Wang Y., Zonderman A.B. Serum antioxidant status is associated with metabolic syndrome among U.S. adults in recent national surveys. J Nutr 2011, 141:903-913.
11. Boekholdt S.M., Meuwese M.C., Day N.E., et al. Plasma concentrations of ascorbic acid and C-reactive protein, and risk of future coronary artery disease, in apparently healthy men and women: the EPIC-Norfolk prospective population study. Br J Nutr 2006, 96:516-522.
12. Simon J.A., Hudes E.S., Tice J.A. Relation of serum ascorbic acid to mortality among US adults. J Am Coll Nutr 2001, 20:255-263.
13. Bjelakovic G., Nikolova D., Gluud L.L., Simonetti R.G., Gluud C. Mortality in randomized trials of antioxidant supplements for primary and secondary prevention: systematic review and meta-analysis. J Am Med Assoc 2007, 297:842-857.
14. Bleys J., Miller E.R., Pastor-Barriuso R., Appel L.J., Guallar E. Vitamin-mineral supplementation and the progression of atherosclerosis: a meta-analysis of randomized controlled trials. Am J Clin Nutr 2006, 84:880-887.
15. Coulter I.D., Hardy M.L., Morton S.C., et al. Antioxidants vitamin C and vitamin E for the prevention and treatment of cancer. J Gen Intern Med 2006, 21:735-744.
16. Lawlor D.A., Smith G.D., Kundu D., Bruckdorfer K.R., Ebrahim S. Those confounded vitamins: what can we learn from the differences between observational versus randomised trial evidence?. Lancet 2004, 363:1724-1727.
17. Kuzyk M.A., Smith D., Yang J., et al. Multiple reaction monitoring-based, multiplexed, absolute quantitation of 45 proteins in human plasma. Mol Cell Proteomics 2009, 8:1860-1877.
18. Didangelos A., Simper D., Monaco C., Mayr M. Proteomics of acute coronary syndromes. Curr Atheroscler Rep 2009, 11:188-195.
19. Mayr M., Mayr U., Chung Y.L., Yin X., Griffiths J.R., Xu Q. Vascular proteomics: linking proteomic and metabolomic changes. Proteomics 2004, 4:3751-3761.
20. Ainsworth B.E., Haskell W.L., Leon A.S., et al. Compendium of physical activities: classification of energy costs of human physical activities. Med Sci Sports Exerc 1993, 25:71-80.
21. Cahill L., Corey P.N., El-Sohemy A. Vitamin C deficiency in a population of young Canadian adults. Am J Epidemiol 2009, 170:464-471.
22. Wagner D., Hanwell H.E., Schnabl K., et al. The ratio of serum 24,25-dihydroxyvitamin D3 to 25-hydroxyvitamin D3 is predictive of 25-hydroxyvitamin D3 response to vitamin D3 supplementation. J Steroid Biochem Mol Biol 2011, 126:72-77.
23. Liu Z., Lee H., Garofalo F., Jenkins D., El-Sohemy A. Simultaneous measurement of three tocopherols, all-trans-retinol, and eight carotenoids in human plasma by isocratic liquid chromatography. J Chromatog Sci 2011, 49:221-227.
24. García-Bailo B., Brenner D., Nielsen D., et al. Dietary patterns and ethnicity are associated with distinct plasma proteomic groups. Am J Clin Nutr 2012, 95:352-361.
25. Faure H., Preziosi P., Roussel A.M., et al. Factors influencing blood concentration of retinol, α-tocopherol, vitamin C, and β-carotene in the French participants of the SU.VI.MAX trial. Eur J Clin Nutr 2006, 60:706-717.
26. Galan P., Viteri F.E., Bertrais S., et al. Serum concentrations of β-carotene, vitamins C and E, zinc and selenium are influenced by sex, age, diet, smoking status, alcohol consumption and corpulence in a general French adult population. Eur J Clin Nutr 2005, 59:1181-1190.
27. Narum S.R. Beyond Bonferroni: less conservative analyses for conservation genetics. Conservation Genetics 2006, 7:783-787.
28. Kramer C.Y. Extension of multiple range tests to group means with unequal numbers of replications. Biometrics 1956, 12:307-310.
29. Daiger S.P., Schanfield M.S., Cavalli-Sforza L.L. Group specific component (Gc) proteins bind vitamin D and 25 hydroxyvitamin D. Proc Natl Acad Sci U S A 1975, 72:2076-2080.
30. Falus A., Rokita H., Walcz E., Brozik M., Hidvegi T., Meretey K. Hormonal regulation of complement biosynthesis in human cell lines-II. Upregulation of the biosynthesis of complement components C3, factor B and C1 inhibitor by interleukin-6 and interleukin-1 in human hepatoma cell line. Mol Immunol 1990, 27:197-201.
31. Perlmutter D.H., Dinarello C.A., Punsal P.I., Colten H.R. Cachectin/tumor necrosis factor regulates hepatic acute-phase gene expression. J Clin Invest 1986, 78:1349-1354.
32. Onat A., Uzunlar B., Hergenç G., et al. Cross-sectional study of complement C3 as a coronary risk factor among men and women. Clin Sci (Lond) 2005, 108:129-135.
33. Muscari A., Massarelli G., Bastagli L., et al. Relationship of serum C3 to fasting insulin, risk factors and previous ischaemic events in middle-aged men. Eur Heart J 2000, 21:1081-1090.
34. Onat A., Can G., Rezvani R., Cianflone K. Complement C3 and cleavage products in cardiometabolic risk. Clin Chim Acta 2011, 412:1171-1179.
35. Esser A.F. The membrane attack complex of complement. Assembly, structure and cytotoxic activity. Toxicology 1994, 87:229-247.
36. Nagata M., Hara T., Aoki T., et al. Inherited deficiency of ninth component of complement: an increased risk of meningococcal meningitis. J Pediatr 1989, 114:260-264.
37. Falcão D.A., Reis E.S., Paixão-Cavalcante D., et al. Deficiency of the human complement regulatory protein factor H associated with low levels of component C9. Scand J Immunol 2008, 68:445-455.
38. Ichikawa E., Furuta J., Kawachi Y., Imakado S., Otsuka F. Hereditary complement (C9) deficiency associated with dermatomyositis. Br J Dermatol 2001, 144:1080-1083.
39. Wintergerst E.S., Maggini S., Hornig D.H. Contribution of selected vitamins and trace elements to immune function. Ann Nutr Metab 2007, 51:301-323.
40. Floris G., Medda R., Padiglia A., Musci G. The physiopathological significance of ceruloplasmin: a possible therapeutic approach. Biochem Pharmacol 2000, 60:1735-1741.
41. Bielli P., Calabrese L. Structure to function relationships in ceruloplasmin: a 'moonlighting' protein. Cell Mol Life Sci 2002, 59:1413-1427.
42. Shukla N., Maher J., Masters J., Angelini G.D., Jeremy J.Y. Does oxidative stress change ceruloplasmin from a protective to a vasculopathic factor?. Atherosclerosis 2006, 187:238-250.
43. Göçmen A.Y., Şahin E., Semiz E., Gümuşlü S. Is elevated serum ceruloplasmin level associated with increased risk of coronary artery disease?. Can J Cardiol 2008, 24:209-212.
44. Janciauskiene S.M., Bals R., Koczulla R., Vogelmeier C., Köhnlein T., Welte T. The discovery of α1-antitrypsin and its role in health and disease. Respir Med 2011, 105:1129-1139.
45. Venkata Rao S., Toora B.D., Ravi Kiran V.S., Indira S. Serum α1-antitrypsin level and antioxidant status in smokers with chronic obstructive pulmonary disease. Biomedicine 2011, 31:27-31.
46. Pongpaew P., Tungtrongchitr R., Phonrat B., Vudhivai N., Viroonudomphol D., Schelp F.P. Tobacco smoking in relation to the phenotype of alpha-1-antitrypsin and serum vitamin C concentration. J Nutr Environ Med 2001, 11:167-173.
47. Morgan L., Pipkin F.B., Kalsheker N. Angiotensinogen: molecular biology, biochemistry and physiology. Int J Biochem Cell Biol 1996, 28:1211-1222.
48. Walker W.G., Whelton P.K., Saito H., Russell R.P., Hermann J. Relation between blood pressure and renin, renin substrate, angiotensin II, aldosterone and urinary sodium and potassium in 574 ambulatory subjects. Hypertension 1979, 1:287-291.
49. Houston M.C. The role of cellular micronutrient analysis, nutraceuticals, vitamins, antioxidants and minerals in the prevention and treatment of hypertension and cardiovascular disease. Ther Adv Cardiovasc Dis 2011, 4:165-183.
50. Brasier A.R., Recinos A., Eledrisi M.S., Runge M.S. Vascular inflammation and the renin-angiotensin system. Arterioscler Thromb Vasc Biol 2002, 22:1257-1266.
51. Sherman C.T., Brasier A.R. Role of signal transducers and activators of transcription 1 and 3 in inducible regulation of the human angiotensinogen gene by interleukin-6. Mol Endocrinol 2001, 15:441-457.
52. White P., Cooke N. The multifunctional properties and characteristics of vitamin D-binding protein. Trends Endocrinol Metab 2000, 11:320-327.
53. Taes Y.E.C., Goemaere S., Huang G., et al. Vitamin D binding protein, bone status and body composition in community-dwelling elderly men. Bone 2006, 38:701-707.
54. Speeckaert M.M., Taes Y.E., De Buyzere M.L., Christophe A.B., Kaufman J.M., Delanghe J.R. Investigation of the potential association of vitamin D binding protein with lipoproteins. Ann Clin Biochem 2010, 47:143-150.
55. Winters S.J., Chennubhatla R., Wang C., Miller J.J. Influence of obesity on vitamin D-binding protein and 25-hydroxy vitamin D levels in African American and white women. Metabolism 2009, 58:438-442.
56. Bolland M.J., Grey A.B., Ames R.W., et al. Age-, gender-, and weight-related effects on levels of 25-hydroxyvitamin D are not mediated by vitamin D binding protein. Clin Endocrinol (Oxf) 2007, 67:259-264.
57. Blanton D., Han Z., Bierschenk L., et al. Reduced serum vitamin D-binding protein levels are associated with type 1 diabetes. Diabetes 2011, 60:2566-2570.
58. Castellino F.J., Ploplis V.A. Structure and function of the plasminogen/plasmin system. Thromb Haemost 2005, 93:647-654.
59. Plow E.F., Hoover-Plow J. The functions of plasminogen in cardiovascular disease. Trends Cardiovasc Med 2004, 14:180-186.
60. Plow E.F., Ploplis V.A., Busuttil S., Carmeliet P., Collen D. A role of plasminogen in atherosclerosis and restenosis models in mice. Thromb Haemost 1999, 82:4-7.
61. Kostka T., Para J., Kostka B. Cardiovascular diseases (CVD) risk factors, physical activity (PA) and plasma plasminogen (Plg) in a random sample of community-dwelling elderly. Arch Gerontol Geriatr 2009, 48:300-305.
62. Folsom A.R., Aleksic N., Park E., Salomaa V., Juneja H., Wu K.K. Prospective study of fibrinolytic factors and incident coronary heart disease: the Atherosclerosis Risk in Communities (ARIC) study. Arterioscler Thromb Vasc Biol 2001, 21:611-617.
63. Cahill L.E., Fontaine-Bisson B., El-Sohemy A. Functional genetic variants of glutathione S-transferase protect against serum ascorbic acid deficiency. Am J Clin Nutr 2009, 90:1411-1417.